Teraklin targets US market for MARS (molecular adsorbents recirculating therapy) liver support product
This article was originally published in Clinica
Executive Summary
German company Teraklin, which develops and manufactures innovative products for extracorporeal blood treatment, is aiming to market its molecular adsorbents recirculating therapy (MARS) in the US as part of its plans for continued international growth.